HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Find → Understand → Decide

Stranded asset discovery

Find leads where development or the surrounding company stopped. Discovery priority is separate from buyer qualification.

Bounded historical coverage · 0 HIGH / 111 MEDIUM / 956 LOW. No current availability or investment recommendation is implied. SEC retrieval is partial.

1067 exact-label leads · page 19

LOW · POSSIBLE / INVESTIGATE

Bcl-XL Proteolysis Targeting Chimera DT2216

Why stranded (event context): safety failure

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · UNKNOWN

BEAM

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · UNKNOWN confidence · New label

LOW · UNKNOWN

Beclomethasone Dipropionate

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · UNKNOWN confidence · New label

LOW · POSSIBLE / INVESTIGATE

Bedaquiline (TMC207)

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · Prior label overlap

LOW · POSSIBLE / INVESTIGATE

Bedaquiline, pretomanid, linezolid

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

Belantamab Mafodotin

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · Prior label overlap

LOW · POSSIBLE / INVESTIGATE

Belinostat

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

Bemarituzumab

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

Bendamustine

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

Best standard treatment

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

BET Bromodomain Inhibitor ZEN-3694

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label

LOW · POSSIBLE / INVESTIGATE

Bevacizumab (Avastin)

Why stranded (event context): inadequate public evidence

Why now: Historical lead requires current reconfirmation; no fresh transaction catalyst established

Company/trial failed before biology? UNKNOWN · Trial reasons are not asset-level verdicts.

Buyer qualification: UNKNOWN · Control: UNKNOWN

MODEL INFERENCE · LOW confidence · New label